Case Study Lecture 6 and 9
Case Study Lecture 6 and 9
The company focuses on continuous improvement and stringent quality controls, ensuring that
its medications meet global regulatory standards. MedCare’s flagship product, a biologic drug
for autoimmune disorders, is widely praised for its quality, offering effective symptom relief and
fewer side effects compared to competitors. However, occasional delays in the production cycle
have raised concerns about meeting delivery deadlines, especially in regions with high demand.
MedCare gathers feedback from its healthcare providers and patients, asking them to rate their
experiences with product quality, availability, and effectiveness. The company also analyzes
shifts in prescription patterns and market share. Additionally, MedCare uses assesses the
responsiveness and knowledge of pharmacy staff distributing its products through disguised
audits. MedCare’s reputation, is built through satisfied doctors and patients’ recommendations.
Evolving healthcare policies and price control regulations in key markets influence MedCare’s
strategies. Exchange rate fluctuations, affect the cost of raw materials and distribution. Increased
awareness of preventive healthcare, drive demand for over-the-counter products, while
advancements in technology enable MedCare to invest in telemedicine platforms and digital
marketing campaigns. However, disruptions in the supply chain caused by climate change, have
occasionally impacted the availability of raw materials.
Questions